Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 616 to 630 of 1809 results for nice guidelines

  1. Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel (DG11)

    Evidence-based recommendations on faecal calprotectin tests for distinguishing between inflammatory bowel diseases (such as Crohn’s disease and ulcerative

  2. Moving between hospital and home, including care homes

    NICE quick guide - moving between hospital and home, including care homes

  3. Freelite assays for diagnosing multiple myeloma and related conditions (terminated assessment) (DG47)

    NICE no longer plans to develop guidance on Freelite assays for diagnosing multiple myeloma and related conditions in primary care. We will review this decision if a stakeholder notifies NICE again of the topic

    Sections for DG47

  4. Better home care for older people

    A quick and easy-to-read guide to the standard of care you should expect from a home care provider.

  5. Clostridium difficile infection: risk with broad-spectrum antibiotics (ESMPB1)

    Summary of the evidence on the risk of using broad-specturm antibiotics associated with clostridium difficile infection

  6. Guidance on the use of glycoprotein IIb/IIIa inhibitors in the treatment of acute coronary syndromes (TA47)

    Evidence-based recommendations on glycoprotein IIb/IIIa inhibitors (abciximab, eptifibatide, tirofiban) for treating acute coronary syndromes in adults.

  7. Understanding intermediate care, including reablement

    A guide to intermediate care services that provide support for a short time to help you recover and increase your independence

  8. Promoting wellbeing and positive identity for a child or young person who is looked after

    information NICE guideline: Looked-after children and young people (NG205) NICE quality standard: Looked-after...

  9. Myocardial infarction: medication for MI more than 12 months ago (IND126)

    This indicator covers the percentage of patients with a history of myocardial infarction (more than 12 months ago) who are currently being treated with an ACE-I (or ARB if ACE-I intolerant), aspirin (or clopidogrel, or anticoagulant drug therapy) and a statin, and a beta-blocker for those patients with left ventricular systolic dysfunction. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM80

  10. Child abuse and neglect guidance

    Find individual child abuse and neglect recommendations quickly and links to full guideline

  11. Abdominal aortic aneurysm

    Awaiting development [GID-QS10035] Expected publication date: TBC

  12. What to expect during assessment and care planning

    A quick guide for people using adult social care services.

  13. Recognition of lung cancer

    The section of the NICE impact lung cancer report looking at how lung cancer is detected.

  14. Stakeholder registration: guidelines, quality standards and indicators

    Register your organisation to help us develop guidelines, quality standards and indicators

  15. Step-by-step guide to registering as a stakeholder

    The process by which organisations can register as stakeholders with NICE.